Immunoglobulins
USED TO TREAT
Immunology-Immunodeficiencies
Neurology-Immune-mediated diseases
Haematology
Dermatology
OUTCOMES
Infection prevention
Regulation of overreacting immune system
Improved quality of life
Increased life expectancy
Plasma
Plasma protein therapies that treat life-threatening disorders and illnesses consist of one main ingredient, plasma. These therapies are uniquely valuable to patients. Without this element with critical functions, treatment would be unavailable, and many lives could have been lost. Our strategic goal for plasma is “ensuring the availability of safe, high-quality plasma for fractionation.”
What is plasma
Plasma is the single largest component of human blood that acts as a transporting medium for cells and a variety of substances vital to the human body. It contains water, salts, enzymes, antibodies, and other proteins. Plasma also carries out many critical functions, including fighting diseases, and is, therefore, essential for numerous therapies.
92%
Water
1%
Other Solutions
7%
Proteins
Plasma collection and manufacturing
Plasma collection
.png)
Plasma manufacturing
Fractionation
Plasma is pooled and processed through a process called "fractionation" that employs time, temperature, pH, and alcohol concentrations to extract specific therapeutic proteins. These are then subjected to various purification methods and viral inactivation and removal processes to further ensure their safety and efficacy.
Plasma therapies
Plasma protein therapies are treatment methods that are relied upon by patients with well-defined medical conditions. Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines.
Plasma protein
Used to treat
Outcomes
Immunoglobulins
- Immunology-Immunodeficiencies
- Neurology-Immune-mediated diseases
- Hematology
- Dermatology
- Infection prevention
- Regulation of overreacting immune system
- Improved quality of life
- Increased life expectancy
Clotting factors
- Bleeding from trauma
- Over dosage of anticoagulants
- Liver disease
- Bleeding Disorders
- Other rare coagulation disorders
- Improved quality of life
- Increased life expectancy
C1 esterase inhibitor
- Hereditary Angioedema
- Improved quality of life
- Increased life expectancy
Plasma for your everyday medicines
Plasma is not only essential for treating rare and chronic diseases — find out more about how plasma is used for everyday medicine, emergencies, surgical and preventive medicine.
Animal bites
(Anti-tetanus IG)
(Anti-rabies IG)
(Anti-rabies IG)
Liver conditions
(Albumin)
Burns
(Albumin)
Cardiopulmonary Issues
(Albumin)
Sicurezza e qualità
La sicurezza e la qualità delle terapie plasma derivate sono la priorità assoluta dell'industria che produce plasma proteine terapeutiche. Sia i centri di raccolta che i centri di lavorazione aderiscono a politiche normative rigorose e hanno stabilito le Good Manufacturing Practices (buone pratiche di fabbricazione) per ogni fase della raccolta del plasma e dei processi di lavorazione.
Registro nazionale dei donatori differiti
Il National Donor Deferral Registry (NDDR) è un database di donatori di plasma permanentemente differiti in Nord America. Tutti i donatori che risultano "reattivi" agli agenti virali dell'HIV, dell'HBV e dell'HCV vengono aggiunti al database e non possono donare plasma presso i centri autorizzati e certificati negli Stati Uniti e in Canada. Si tratta di una misura essenziale per l'industria per garantire la sicurezza delle terapie finali.
Patients notification system
Il Patient Notification System (PNS) è un sistema di comunicazione gratuito, confidenziale e attivo 24 ore su 24 che notifica ai pazienti e agli utenti registrati i ritiri e i richiami delle terapie plasma derivate. Questo sistema consente al paziente e ad ogni utente registrato di ricevere informazioni importanti direttamente via e-mail, telefono, SMS o fax.
Disponibilità di plasma
Con il sistema web-based di PPTA, potrai garantirti un accesso completo su base mensile dei dati relativi alle corrette terapie a base di proteine plasmatiche.
